499 related articles for article (PubMed ID: 6201554)
1. Soluble factors produced during an immune response regulate Ia antigen expression by murine adenocarcinoma and fibrosarcoma cells.
Callahan GN
J Immunol; 1984 May; 132(5):2649-57. PubMed ID: 6201554
[TBL] [Abstract][Full Text] [Related]
2. Immune selection in murine tumors. Ph.d thesis.
Svane IM; Engel AM
APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251
[TBL] [Abstract][Full Text] [Related]
3. Identification of Ia antigens on the murine adenocarcinoma LT-85.
Giedlin MA; Martin WJ; Callahan GN
J Natl Cancer Inst; 1983 Oct; 71(4):825-34. PubMed ID: 6578374
[TBL] [Abstract][Full Text] [Related]
4. In vivo treatment with monoclonal anti-I-A antibodies: disappearance of splenic antigen-presenting cell function concomitant with modulation of splenic cell surface I-A and I-E antigens.
Kruisbeek AM; Titus JA; Stephany DA; Gause BL; Longo DL
J Immunol; 1985 Jun; 134(6):3605-14. PubMed ID: 2580891
[TBL] [Abstract][Full Text] [Related]
5. Induction of Ia and H-2 antigens on a macrophage cell line by immune interferon.
King DP; Jones PP
J Immunol; 1983 Jul; 131(1):315-8. PubMed ID: 6408177
[TBL] [Abstract][Full Text] [Related]
6. Systemic immunologic stimuli increase class I and II antigen expression in mouse kidney.
Halloran PF; Jephthah-Ochola J; Urmson J; Farkas S
J Immunol; 1985 Aug; 135(2):1053-60. PubMed ID: 3891851
[TBL] [Abstract][Full Text] [Related]
7. Cell-mediated immune responses to syngeneic tumors. I. Identification of two distinct CTL effector pathways which differ in antigen specificity, genetic regulation, and cell surface phenotype.
Lynch DH; Daynes RA; Hodes RJ
J Immunol; 1986 Feb; 136(4):1521-7. PubMed ID: 2418117
[TBL] [Abstract][Full Text] [Related]
8. Biochemical evidence for expression of a semi-allogeneic, H-2 antigen by a murine adenocarcinoma.
Callahan GN; Pardi D; Giedlin MA; Allison JP; Morizot DM; Martin WJ
J Immunol; 1983 Jan; 130(1):471-9. PubMed ID: 6847892
[TBL] [Abstract][Full Text] [Related]
9. The isolation and functional characterization of autoimmune clones expressing inappropriate Ia.
Cronin PS; Sing AP; Glimcher LH; Kelley VE; Reinisch CL
J Immunol; 1984 Aug; 133(2):822-9. PubMed ID: 6610712
[TBL] [Abstract][Full Text] [Related]
10. Characterization of a cloned ultraviolet radiation (UV)-induced suppressor T cell line that is capable of inhibiting anti-UV tumor-immune responses.
Roberts LK
J Immunol; 1986 Mar; 136(5):1908-16. PubMed ID: 2936813
[TBL] [Abstract][Full Text] [Related]
11. Production of BSF-1 during an in vivo, T-dependent immune response.
Finkelman FD; Ohara J; Goroff DK; Smith J; Villacreses N; Mond JJ; Paul WE
J Immunol; 1986 Nov; 137(9):2878-85. PubMed ID: 3489779
[TBL] [Abstract][Full Text] [Related]
12. Immune response to progressor variants derived from transfection of an ultraviolet radiation-induced C3H mouse regressor tumor cell line with activated Harvey-ras oncogene.
Kaba DS; Pierceall WE; Price JE; Ananthaswamy HN
Cancer Res; 1990 Jun; 50(11):3159-66. PubMed ID: 2185882
[TBL] [Abstract][Full Text] [Related]
13. Keratinocytes synthesize Ia antigen in acute cutaneous graft-vs-host disease.
Breathnach SM; Katz SI
J Immunol; 1983 Dec; 131(6):2741-5. PubMed ID: 6417231
[TBL] [Abstract][Full Text] [Related]
14. Correlation of in vitro and in vivo studies of antigens relevant to the control of murine breast cancer.
Stutman O
Cancer Res; 1976 Feb; 36(2 pt 2):739-47. PubMed ID: 175934
[TBL] [Abstract][Full Text] [Related]
15. In vivo treatment with anti-I-A antibodies: differential effects on Ia antigens and antigen-presenting cell function of spleen cells and epidermal Langerhans cells.
Aberer W; Kruisbeek AM; Shimada S; Katz SI
J Immunol; 1986 Feb; 136(3):830-6. PubMed ID: 3455705
[TBL] [Abstract][Full Text] [Related]
16. Expression of H-2 antigens and inducibility of antitumor immune responses in various tumor cell clones established from methylcholanthrene-induced fibrosarcomas.
Ogata M; Shimizu J; Kosaka H; Maekawa R; Shimizu K; Fujiwara H; Hamaoka T
Jpn J Cancer Res; 1986 Nov; 77(11):1134-41. PubMed ID: 3098723
[TBL] [Abstract][Full Text] [Related]
17. IA mutant functional antigen-presenting cell lines.
Glimcher LH; Hamano T; Asofsky R; Sachs DH; Pierres M; Samelson LE; Sharrow SO; Paul WE
J Immunol; 1983 May; 130(5):2287-94. PubMed ID: 6300242
[TBL] [Abstract][Full Text] [Related]
18. Antigen form influences induction and frequency of influenza-specific class I and class II MHC-restricted cytolytic T lymphocytes.
Morrison LA; Braciale VL; Braciale TJ
J Immunol; 1988 Jul; 141(2):363-8. PubMed ID: 2454989
[TBL] [Abstract][Full Text] [Related]
19. Establishment of a continuous T cell line capable of suppressing anti-tumor immune responses in vivo.
Roberts LK; Spellman CW; Warner NL
J Immunol; 1983 Jul; 131(1):514-9. PubMed ID: 6223081
[TBL] [Abstract][Full Text] [Related]
20. Interferon-gamma induces enhanced expression of Ia and H-2 antigens on B lymphoid, macrophage, and myeloid cell lines.
Wong GH; Clark-Lewis I; McKimm-Breschkin L; Harris AW; Schrader JW
J Immunol; 1983 Aug; 131(2):788-93. PubMed ID: 6408189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
